Conmed Q3 2024 Adj. EPS $1.05 Beats $0.99 Estimate, Sales $316.701M Miss $318.128M Estimate
Portfolio Pulse from Benzinga Newsdesk
Conmed (NYSE:CNMD) reported Q3 2024 earnings per share of $1.05, surpassing the analyst estimate of $0.99. However, sales were $316.701 million, slightly below the expected $318.128 million. Sales increased by 3.98% compared to the same period last year.
October 30, 2024 | 8:36 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Conmed's Q3 2024 earnings per share exceeded expectations, but sales slightly missed estimates. Despite the sales miss, there was a year-over-year increase in sales.
Conmed's earnings per share beat expectations, which is a positive indicator for the stock. The slight miss in sales is offset by the year-over-year growth, suggesting a generally positive outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100